Human and chicken antibodies to CCR5-ECL1 block mucosal and systemic HIV infection

Lucia Lopalco(Vita-Salute San Raffaele University), Adriano Lazzarin(Vita-Salute San Raffaele University), Renato Longhi(Institute of Chemistry of Molecular Recognition), Morgane Bomsel(Centre National de la Recherche Scientifique), Giorgio Colombo(University of Pavia), Lorenzo Diomede(Vita-Salute San Raffaele University), Roberto Consonni(Construction Technologies Institute), Claudia Pastori(Vita-Salute San Raffaele University), Chiara Alberti, Alberto Clivio(Tecnologie Avanzate (Italy))
Retrovirology
December 1, 2006
10.1186/1742-4690-3-s1-s14
Cited by 0

Related Papers

Efficacy of Enfuvirtide in Patients Infected with Drug-Resistant HIV-1 in Europe and Australia
|New England Journal of Medicine|2003|653
Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial
|The Lancet|2009|620
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors
|Clinical Microbiology and Infection|2020|391
Rational design of shepherdin, a novel anticancer agent
|Cancer Cell|2005|348
Control of HIV despite the Discontinuation of Antiretroviral Therapy
|New England Journal of Medicine|1999|328